About Contact Us Careers
Sign In

Auto-Injector Market - Top Companies and Manufacturers

  • Report ID: 3511
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the Auto-injectors Landscape

    • Eli Lilly and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Scandinavian Health Ltd.
    • AbbVie, Inc.
    • Amgen
    • Owen Mumford
    • Ypsomed
    • Biogen Idec
    • Mylan N.V.
    • Pfizer, Inc.
    •  Sanofi
    • Stevanato Group
    • Teva Pharmaceutical
Browse Key Market Insights with Data Illustration:

In the News

  • Eli Lilly and Company announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Mounjaro (tirzepatide) injection a single molecule that activates the body's receptors for GIP and GLP-1 for people living with type 2 diabetes to assist individuals in obtaining the prescription drugs they are prescribed, and it will collaborate with physicians, insurers, and health systems to facilitate patient access to Mounjaro.
  • Stevanato Group together with Owen Mumford to expedite the Aidaptus auto-injector's manufacturing process and also provide pharmaceutical clients with pre-filled syringes so they may administer the finished product to patients.

Author Credits:  Radhika Pawar


  • Report ID: 3511
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of auto-injectors is estimated at USD 10.18 billion.

The auto-injectors market size was over USD 9.27 billion in 2024 and is poised to cross USD 41.88 billion by the end of 2037, witnessing more than 12.3% CAGR during the forecast period i.e., between 2025-2037. Rising cases of rheumatoid arthritis and the growing government initiatives to increase awareness will drive the market growth.

North America industry is estimated to account for largest revenue share 45% by 2037, impelled by rising investment in the healthcare sector in the region.

The major players in the market are Scandinavian Health Ltd., AbbVie, Inc., Amgen, Owen Mumford, Ypsomed, Biogen Idec, Mylan N.V., Pfizer, Inc., Sanofi, and Stevanato Group.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample